Characteristics | All Patients, n = 82; All Infusions, n = 2446 | All Patients with IR, n = 14 | All Infusions, n = 2446 |
---|---|---|---|
Patients with IR, n (%) | 14 (17) | 14 (100) | |
No. patients with IR/100 patient-yrs | 5.1 | ||
IR, n (%) | 46 (2) | 46 (100) | |
IR/100 patient-yrs | 16.9 | ||
Severity of IR, n (%) | |||
Mild | 12 (26) | 6 (43) | 12 (26) |
Moderate | 34 (74) | 11 (79) | 34 (74) |
Severe | 0 | 0 | |
Symptoms during IR, n (%) | |||
Respiratory | 33 (72) | 10 (71) | 33 (72) |
Dyspnea | 22 (48) | 7 (50) | 22 (48) |
Cough | 19 (41) | 7 (50) | 19 (41) |
Wheezing | 5 (11) | 4 (29) | 5 (11) |
Malaise | 28 (61) | 12 (86) | 28 (61) |
Cutaneous (flush, rash) | 27 (59) | 8 (57) | 27 (59) |
Gastrointestinal | 6 (13) | 5 (36) | 6 (13) |
Abdominal pain | 1 (2) | 1 (7) | 1 (2) |
Diarrhea and vomiting | 5 (11) | 4 (29) | 5 (11) |
Hypotonia/tachycardia | 0 | 0 | 0 |
Treatment during IR, n (%) | |||
Antihistamine IV (clemastine) | 39 (85) | 13 (93) | 39 (85) |
Corticosteroid IV (methylprednisolone) | 22 (48) | 10 (71) | 22 (48) |
Epinephrine inhalation | 6 (13) | 2 (14) | 6 (13) |
Albuterol inhalation | 1 (2) | 1 (7) | 1 (2) |
IV: intravenous.